T2 Biosystems, Inc. (TTOO): Price and Financial Metrics

T2 Biosystems, Inc. (TTOO)

Today's Latest Price: $1.31 USD

0.01 (-0.76%)

Updated Oct 20 4:00pm

Add TTOO to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

TTOO Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for TTOO is -2.24 -- better than just 4.11% of US stocks.
  • With a price/sales ratio of 19.84, T2 Biosystems Inc has a higher such ratio than 92.05% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -2.33 for T2 Biosystems Inc; that's greater than it is for just 4.74% of US stocks.
  • If you're looking for stocks that are quantitatively similar to T2 Biosystems Inc, a group of peers worth examining would be APM, SENS, INSM, URG, and NSTG.
  • Visit TTOO's SEC page to see the company's official filings. To visit the company's web site, go to www.t2biosystems.com.

TTOO Stock Price Chart Interactive Chart >

Price chart for TTOO

TTOO Price/Volume Stats

Current price $1.31 52-week high $3.15
Prev. close $1.32 52-week low $0.24
Day low $1.30 Volume 1,387,300
Day high $1.34 Avg. volume 10,154,842
50-day MA $1.38 Dividend yield N/A
200-day MA $1.07 Market Cap 193.81M

T2 Biosystems, Inc. (TTOO) Company Bio

T2 Biosystems develops diagnostic products and product candidates for the detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types. The company was founded in 2006 and is based in Lexington, Massachusetts.

TTOO Latest News Stream

Event/Time News Detail
Loading, please wait...

TTOO Latest Social Stream

Loading social stream, please wait...

View Full TTOO Social Stream

Latest TTOO News From Around the Web

Below are the latest news stories about T2 Biosystems Inc that investors may wish to consider to help them evaluate TTOO as an investment opportunity.

COVID-19 Opportunity Knocks, T2 Answers

T2 (TTOO), one of the stocks that I have followed for my speculative biotech portfolio, has been on the emergency floor for a while. I consider it as being in the danger zone because it is struggling to commercialize its suite of FDA approved testing devices as I describe below....

Out of Ignorance on Seeking Alpha | August 14, 2020

T2 Biosystems, Inc. (TTOO) CEO John Sperzel on Q2 2020 Results - Earnings Call Transcript

T2 Biosystems, Inc. (TTOO) Q2 2020 Earnings Conference Call August 11, 2020 04:30 PM ET Company Participants Philip Taylor - Investor Relations John Sperzel - President & Chief Executive Officer John Sprague - Chief Financial Officer Tom Lowery - Chief Scientific Officer Conference Call Participants Puneet Souda - SVB Leerink...

SA Transcripts on Seeking Alpha | August 12, 2020

T2 Biosystems Announces Second Quarter 2020 Financial Results

LEXINGTON, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today…

GlobeNewswire | August 11, 2020

Earnings Outlook for T2 Biosystems

T2 Biosystems (NASDAQ: TTOO) announces its next round of earnings this Tuesday, August 11. Here is Benzinga's everything-that-matters guide for this …

Benzinga | August 10, 2020

T2 Biosystems to Participate in the Canaccord Genuity Annual Growth Conference

LEXINGTON, Mass., July 30, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming virtual Canaccord Genuity Annual Growth Conference. Management is scheduled to present Thursday, August 13, 2020 at 9:30am ET. Interested parties may access a live and recorded webcast of the presentation on the “Investors” section of the Company’s website at www.t2biosystems.com.  About T2 Biosystems T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrumen...

Yahoo | July 30, 2020

Read More 'TTOO' Stories Here

TTOO Price Returns

1-mo 6.50%
3-mo -18.63%
6-mo 147.31%
1-year -44.73%
3-year -67.65%
5-year -88.93%
YTD 11.97%
2019 -61.13%
2018 -26.94%
2017 -21.67%
2016 -51.92%
2015 -43.14%

Continue Researching TTOO

Want to see what other sources are saying about T2 Biosystems Inc's financials and stock price? Try the links below:

T2 Biosystems Inc (TTOO) Stock Price | Nasdaq
T2 Biosystems Inc (TTOO) Stock Quote, History and News - Yahoo Finance
T2 Biosystems Inc (TTOO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7742 seconds.